Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06756035
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:31.980957+00:00
Published At
2025-07-31T00:00:00+00:00
Record Updated At
2025-07-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mesothelin-Expressing Tumors", "Epithelial Ovarian Cancer", "Malignant Pleural Mesothelioma, Advanced", "Malignant Peritoneal Mesothelioma, Advanced", "Pancreatic Adenocarcinoma Advanced or Metastatic", "Lung Adenocarcinoma Metastatic", "Cholangiocarcinoma Advanced", "Cholangiocarcinoma Non-resectable", "Mesothelin-expressing Advanced Cancers", "Mesothelin-positive Advanced Malignant Solid Tumors", "Colorectal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-31"
protocolSection.identificationModule.nctId
"NCT06756035"
protocolSection.identificationModule.officialTitle
"Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Mesothelin-Expressing Tumors (protocolSection.conditionsModule.conditions)
  • Epithelial Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Malignant Pleural Mesothelioma, Advanced (protocolSection.conditionsModule.conditions)
  • Malignant Peritoneal Mesothelioma, Advanced (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma Advanced or Metastatic (protocolSection.conditionsModule.conditions)
  • Lung Adenocarcinoma Metastatic (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma Advanced (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma Non-resectable (protocolSection.conditionsModule.conditions)
  • Mesothelin-expressing Advanced Cancers (protocolSection.conditionsModule.conditions)
  • Mesothelin-positive Advanced Malignant Solid Tumors (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.